SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 254.87 |
Enterprise Value ($M) | 255.01 |
Book Value ($M) | -8.93 |
Book Value / Share | -0.38 |
Price / Book | -28.54 |
NCAV ($M) | -255.83 |
NCAV / Share | -10.75 |
Price / NCAV | -1.00 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | 0.05 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.48 |
Current Ratio | 0.48 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 0.26 |
Assets | 247.15 |
Liabilities | 256.09 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Fort Baker Capital Management LP | 5.51 | ||
13G | Vivaldi Asset Management, LLC | 5.30 | ||
13G | HGC Investment Management Inc. | 8.38 | ||
13G | Wealthspring Capital LLC | 9.40 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
CTLT – Catalent, Inc. | EBS – Emergent BioSolutions Inc. |
ELAN – Elanco Animal Health Incorporated | JNJ – Johnson & Johnson |
LLY – Eli Lilly and Company |
Financial data and stock pages provided by
Fintel.io